about
Histone deacetylase inhibition synergistically enhances pemetrexed cytotoxicity through induction of apoptosis and autophagy in non-small cell lung cancer.Aurora Kinase A expression is associated with lung cancer histological-subtypes and with tumor de-differentiation.Targeted next-generation sequencing of cancer genes in advanced stage malignant pleural mesothelioma: a retrospective study.MicroRNAs in non-small cell lung cancer: current status and future therapeutic promises.ATF2 contributes to cisplatin resistance in non-small cell lung cancer and celastrol induces cisplatin resensitization through inhibition of JNK/ATF2 pathway.Tumor/stromal caveolin-1 expression patterns in pleural mesothelioma define a subgroup of the epithelial histotype with poorer prognosis.Dasatinib modulates sensitivity to pemetrexed in malignant pleural mesothelioma cell lines.Precision medicine in age-specific non-small-cell-lung-cancer patients: Integrating biomolecular results into clinical practice-A new approach to improve personalized translational research.Effects of Src kinase inhibition induced by dasatinib in non-small cell lung cancer cell lines treated with cisplatin.Polymerase eta mRNA expression predicts survival of non-small cell lung cancer patients treated with platinum-based chemotherapy.Expression analysis of genes involved in DNA repair or synthesis in mixed neuroendocrine/nonneuroendocrine carcinomas.Retrospective study testing next generation sequencing of selected cancer-associated genes in resected prostate cancer.Heterogeneity of large cell carcinoma of the lung: an immunophenotypic and miRNA-based analysis.Molecular and Histopathological Characterization of the Tumor Immune Microenvironment in Advanced Stage of Malignant Pleural Mesothelioma.Messenger RNA and protein expression of thymidylate synthase and DNA repair genes in thymic tumors.p63 and p73 isoform expression in non-small cell lung cancer and corresponding morphological normal lung tissueDynamic Interplay between Pericytes and Endothelial Cells during Sprouting Angiogenesis
P50
Q34346813-0B2158A8-62DB-4C04-8FD8-EEF98E1AD44BQ35142318-2DEF9021-8109-4E39-89E8-2A1E6D6E7279Q35525069-A6BF195E-2943-4126-934F-4AAD3B9E52BFQ38153833-CF8BBA3E-DBCF-4460-AE81-46C75BDCD379Q38943647-ADD6EEB3-0C76-497B-AE7C-4F3704A1FFE0Q38994061-B79B7EB8-3CF0-4256-AB6E-F2BF9641B2C2Q39621469-E65B139F-DC65-4BC4-BE2C-AD9630EF2075Q39653723-09723F53-2E94-42FE-A145-A27611A3B1B1Q39782838-3CF282A4-0AF8-4C6C-A7B6-A07F77AC28C6Q39888318-C67DB4B8-2C2C-4D2F-9994-03CC6E9A6163Q41508710-6E2EA542-C9E8-41AA-A5E7-DAE7A811BBBAQ42530532-A956355A-EB34-45E9-9233-FE242057521CQ44280426-D197EA74-86B2-4E19-8DFF-DCBEA4CC216CQ46089043-62B0DE07-3687-43C7-B7AB-AA64E9E2E58FQ46193351-9E0232E1-6371-4228-BB0C-E409191EA5D1Q83357806-0B446EE3-480C-4F76-99B4-BDEC8CC082CCQ90226784-012ED8A1-A7CC-445F-A8A5-410909E5ADDC
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Valentina Monica
@ast
Valentina Monica
@en
Valentina Monica
@es
Valentina Monica
@nl
type
label
Valentina Monica
@ast
Valentina Monica
@en
Valentina Monica
@es
Valentina Monica
@nl
prefLabel
Valentina Monica
@ast
Valentina Monica
@en
Valentina Monica
@es
Valentina Monica
@nl
P106
P1153
26039267900
P31
P496
0000-0002-6598-0826